| Neutrophils dominate the immune cell composition in non-small cell lung cancer J Kargl, SE Busch, GHY Yang, KH Kim, ML Hanke, HE Metz, JJ Hubbard, ... Nature communications 8 (1), 14381, 2017 | 399 | 2017 |
| Mutant IDH1 regulates the tumor-associated immune system in gliomas NM Amankulor, Y Kim, S Arora, J Kargl, F Szulzewsky, M Hanke, ... Genes & development 31 (8), 774-786, 2017 | 387 | 2017 |
| GPR55 ligands promote receptor coupling to multiple signalling pathways CM Henstridge, NAB Balenga, R Schröder, JK Kargl, W Platzer, L Martini, ... British journal of pharmacology 160 (3), 604-614, 2010 | 259 | 2010 |
| GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils NAB Balenga, E Aflaki, J Kargl, W Platzer, R Schröder, S Blättermann, ... Cell research 21 (10), 1452-1469, 2011 | 239 | 2011 |
| Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis AD Gregory, CR Kliment, HE Metz, KH Kim, J Kargl, BA Agostini, LT Crum, ... Journal of Leucocyte Biology 98 (2), 143-152, 2015 | 194 | 2015 |
| Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 CM Henstridge, NAB Balenga, J Kargl, C Andradas, AJ Brown, A Irving, ... Molecular endocrinology 25 (11), 1835-1848, 2011 | 180 | 2011 |
| Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival A Theiler, T Bärnthaler, W Platzer, G Richtig, M Peinhaupt, S Rittchen, ... Journal of Allergy and Clinical Immunology 144 (3), 764-776, 2019 | 178 | 2019 |
| Lung cancer subtypes generate unique immune responses SE Busch, ML Hanke, J Kargl, HE Metz, D MacPherson, AMG Houghton The Journal of Immunology 197 (11), 4493-4503, 2016 | 161 | 2016 |
| Nicotinamide for the treatment of heart failure with preserved ejection fraction M Abdellatif, V Trummer-Herbst, F Koser, S Durand, R Adão, ... Science translational medicine 13 (580), eabd7064, 2021 | 158 | 2021 |
| Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC J Kargl, X Zhu, H Zhang, GHY Yang, TJ Friesen, M Shipley, DY Maeda, ... JCI insight 4 (24), e130850, 2019 | 152 | 2019 |
| Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling NA Balenga, E Martínez‐Pinilla, J Kargl, R Schröder, M Peinhaupt, ... British journal of pharmacology 171 (23), 5387-5406, 2014 | 150 | 2014 |
| Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma JR Veatch, SM Lee, M Fitzgibbon, IT Chow, B Jesernig, T Schmitt, ... The Journal of clinical investigation 128 (4), 1563-1568, 2018 | 143 | 2018 |
| Macrophage-dependent cytoplasmic transfer during melanoma invasion in vivo M Roh-Johnson, AN Shah, JA Stonick, KR Poudel, J Kargl, GH Yang, ... Developmental cell 43 (5), 549-562. e6, 2017 | 134 | 2017 |
| Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non–small cell lung cancer NM Mark, J Kargl, SE Busch, GHY Yang, HE Metz, H Zhang, JJ Hubbard, ... American Journal of Respiratory and Critical Care Medicine 197 (3), 325-336, 2018 | 115 | 2018 |
| GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis J Kargl, L Andersen, C Hasenöhrl, D Feuersinger, A Stančić, A Fauland, ... British journal of pharmacology 173 (1), 142-154, 2016 | 114 | 2016 |
| The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 J Kargl, N Balenga, GP Parzmair, AJ Brown, A Heinemann, M Waldhoer Journal of Biological Chemistry 287 (53), 44234-44248, 2012 | 113 | 2012 |
| A selective antagonist reveals a potential role of G protein–coupled receptor 55 in platelet and endothelial cell function J Kargl, AJ Brown, L Andersen, G Dorn, R Schicho, M Waldhoer, ... The Journal of pharmacology and experimental therapeutics 346 (1), 54-66, 2013 | 101 | 2013 |
| Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations JR Veatch, BL Jesernig, J Kargl, M Fitzgibbon, SM Lee, C Baik, R Martins, ... Cancer immunology research 7 (6), 910-922, 2019 | 87 | 2019 |
| Immune regulatory processes of the tumor microenvironment under malignant conditions K Pansy, B Uhl, J Krstic, M Szmyra, K Fechter, A Santiso, L Thüminger, ... International journal of molecular sciences 22 (24), 13311, 2021 | 86 | 2021 |
| Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target P Valadez-Cosmes, S Raftopoulou, ZN Mihalic, G Marsche, J Kargl Pharmacology & Therapeutics 236, 108052, 2022 | 66 | 2022 |
